Key Highlights
- The Munich Regional Court ruled there was imminent infringement for Merck & Co.’s Keytruda SC in Germany related to Halozyme’s MDASE patents in Europe, the San Diego company said.
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case
The Munich Regional Court ruled there was imminent infringement for Merck & Co.’s Keytruda SC in Germany related to Halozyme’s MDASE patents in Europe, the San Diego company said.
Loading ad...
Loading ad...
Sources
This quick summary is automatically generated using AI based on reports from multiple news sources. The content has not been reviewed or verified by humans. For complete details, accuracy, and context, please refer to the original published articles.
